<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Diagnostic accuracy of isotropic FLAIR-T2*fusion imaging for central vein sign detection in multiple sclerosis: a comparative study at 1.5 T and 3 T

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,

Program

Organization Authors

Co-Authors

Date

Language

Embargo Status

No

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Purpose The central vein sign (CVS) is a promising imaging biomarker for multiple sclerosis (MS) diagnosis. While isotropic T2* at 3 T and 7 T has demonstrated high diagnostic performance, its utility at 1.5 T remains unclear. This study evaluates the performance of unenhanced FLAIR-T2* fusion at 1.5 T compared to 3 T in MS participants. Methods This prospective observational study included 20 MS patients and 20 control subjects. Each participant underwent unenhanced isotropic Epi-T2* and isotropic FLAIR (0.8 mm voxel size) at both 1.5 T and 3 T. Subsequently, the derived isotropic T2* and FLAIR were combined to create the final FLAIR-T2* fusion in both magnetic field strengths. Two independent raters assessed the CVS status of white matter (WM) lesions using NAIMS criteria. WM lesions were classified as CVS+ or CVS-, and two methods-select-n* and CVS+ proportion-were applied. Sensitivity and specificity were computed, and CVS performance was compared across WM lesion locations. Results Among eligible WM lesions (MS: 258; controls: 255), the mean CVS+ lesion proportion per participant was 66.9 +/- 15.4% for 1.5 T FLAIR-T2* and 77.0 +/- 13.6% for 3 T FLAIR-T2* (p < 0.01). At a 40% threshold, 1.5 T FLAIR-T2* achieved 90% sensitivity and 95% specificity, while 3 T FLAIR-T2* achieved 100% sensitivity and 95% specificity. The Select-6* method resulted in only one MS patient being misclassified at both field strengths. 3 T FLAIR-T2* detected more CVS+ lesions in deep WM (87.5% vs. 57.1%, p = 0.05). Conclusion 1.5 T FLAIR-T2* fusion demonstrates high performance in CVS assessment, although slightly outperformed by 3 T FLAIR-T2*. The select-6* method may enhance 1.5 T performance, supporting its feasibility for CVS evaluation.

Source

Publisher

Springer Heidelberg

Citation

item.page.haspartof

Source

Clinical Neuroradiology

item.page.ispartofseries

item.page.edition

DOI

10.1007/s00062-025-01531-6

item.page.datauri

item.page.link

Rights

CC BY (Attribution)

Copyrights Note

Creative Commons license

Except where otherwise noted, this item's license is described as CC BY (Attribution)

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators